Brain Implant Technology Lets Paralysis Patients Move, Touch, and Feel With Their Thoughts “The BCI research community is extremely vibrant. They are looking at everything from [enabling people to] walk again, see again, hear again, and even feel again. Anything you can think of, they are researching it,” said Marcus Gerhardt, CEO of Blackrock Neurotech,…
DetailsHigh Performing Algorithm To Translate Paralyzed Patients’ Thoughts Into Real-Time Prosthetic Movements Blackrock Neurotech to enhance thought-to-prosthetic movement for paralyzed BCI patients by licensing proprietary algorithm from Columbia University. SALT LAKE CITY, Feb. 8, 2022 /PRNewswire/ — Blackrock Neurotech, the leader in brain-computer interface (BCI) technology, has signed an exclusive license for Columbia University’s neural decoder MINT. The license…
DetailsThought to text: brain-computer interface lets you type, move robotic arms with your mind Thinking to type sounds interesting to most of us. Crazy and futuristic, yes, but also freeing and fast. But for those with massive spinal cord injuries or degenerative diseases, brain-computer interface technology is an absolute lifeline. In this TechFirst, we…
DetailsExclusive Interview with Marcus Gerhardt, CEO of Blackrock Neurotech With the digital transformation taking over the world, the medical industry is also following in its footsteps. In a small span of time, neurotechnology has advanced a lot and it has been a breakthrough in the health industry. Blackrock Neurotech provides innovative tools and neurotech expertise to…
DetailsWhy Building a Community is Crucial for Medical Device Startups: Interview with Blackrock Neurotech Co-Founder and CEO Marcus Gerhardt A common thread runs through Marcus Gerhardt’s career: If a company involves technology and disruption, it’s probably calling his name. Marcus co-founded Blackrock Neurotech in 2008 with his long-time friend and business partner, Florian Solzbacher. Blackrock’s MoveAgain brain-computer interface…
DetailsBlackrock Neurotech – MoveAgain Brain-Computer Interface System Professor Florian Solzbacher, Co-Founder, Chairman, and President of Blackrock Neurotech discusses the MoveAgain Brain-Computer Interface (BCI) System that the FDA has granted a Breakthrough Device designation. It utilizes an array (electrode) implanted in the brain, which decodes intended movement from neuronal activity in the brain. This game-changing portable BCI…
DetailsBCIs had a big year in the lab. In 2022, they’re coming to the market Brain-computer interfaces are slowly edging into the mainstream. After a string of scientific breakthroughs, neurotech companies are starting to commercialize their research. Among them is Blackrock Neurotech, which focuses on restoring functions that have been impaired by disabilities or accidents. The company is best-known for…
DetailsThought-to-Text Brain-Computer Interface: Interview with Florian Solzbacher, Chairman of Blackrock Neurotech Blackrock Neurotech, a medical technology company based in Salt Lake City, created a suite of brain-computer interface systems with the goal of empowering patients to have increased independence and quality of life. This latest technology aims to restore written communication in patients who…
DetailsGroundbreaking Brain Computer Interface Technology Expected to Achieve Partial Restoration of Communication Function in Impaired Patients SALT LAKE CITY, Nov. 30, 2021 /PRNewswire/ — Blackrock Neurotech, the leader in brain-computer interface (BCI) technology, has announced plans to commercialize a BCI platform in 2022, with the aim of restoring communication function in patients impaired by disabilities…
DetailsBlackrock Neurotech’s MoveAgain Brain-Computer Interface System Receives Breakthrough Device Designation from the FDA SALT LAKE CITY, Nov. 16, 2021 /PRNewswire/ — Blackrock Neurotech, the leader in brain-computer interface technology, today announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its groundbreaking MoveAgain Brain Computer Interface (BCI) System. The first-of-its-kind system is…
Details| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |